Clinical Trial Update: Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating the safety and potential neuroprotective effects of Scp776 in patients with acute ischem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Scp776 (Scp776)

Snippet

Sponsor: Silver Creek Pharmaceuticals | Conditions: Acute Ischemic Stroke (AIS) | Phase 2 | Status: COMPLETED